SCHEMBL7308342

SCHEMBL7308342

COc1ccc([S+]([O-])C(C)(C)CC(=O)NO)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 9/20 0.46
MMP2 P08253 5/20 0.44
MMP3 P08254 5/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
HDAC1 Q13547 4/20 0.43
HDAC8 Q9BY41 4/20 0.43
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
MMP8 P22894 4/20 0.43
MMP12 P39900 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870722 0.75 MMP1 (0.56) MMP1HDAC1HDAC8HDAC3HDAC4
SCHEMBL6823261 0.72 MMP1 (0.59) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL6933354 0.72 MMP1 (0.60) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL6932404 0.72 MMP13 (0.60) MMP1HDAC1HDAC8HDAC3HDAC2
SCHEMBL7298900 0.71 MMP1 (0.48) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL22912675 0.70 CA1 (0.48) MMP13CA1CA2
SCHEMBL6930501 0.69 HDAC1 (0.60) MMP1HDAC1HDAC8HDAC3HDAC4
SCHEMBL6931713 0.69 HDAC1 (0.60) MMP1HDAC1HDAC8HDAC3HDAC4
SCHEMBL11986318 0.69 CA1 (0.42) CA1CA2
SCHEMBL11986321 0.69 CA1 (0.42) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed